CAPR
CAPRICOR THERAPEUTICS, INC.
Key Financials
Revenue
$0
↓ 100.0%
Operating Income
$-108142130
↓ 154.1%
Total Liabilities
$50.2M
↑ 100.5%
EPS (Diluted)
$-2.26
↓ 96.5%
Shareholders' Equity
$305.8M
↑ 110.2%
Cash & Equivalents
$287.8M
↑ 2450.3%
Total Assets
$355.9M
↑ 108.8%
Net Income
$-105043946
↓ 159.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| SCHEDULE 13G | 8/7/2026 | View on SEC |
| SCHEDULE 13G | 8/3/2026 | View on SEC |
| 8-K | 7/30/2026 | View on SEC |
| 8-K | 7/29/2026 | View on SEC |
| 8-K | 7/14/2026 | View on SEC |
| 4 | 6/29/2026 | View on SEC |
| 4 | 6/29/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CAPR |
| Company Name | CAPRICOR THERAPEUTICS, INC. |
| CIK | 1133869 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (310) 358-3200 |